Latest updates for Aml
Fresh curated links around AML are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Amyloidosis Continues To Fight Back
- AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial
- Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
finance.yahoo.com
/3 weeks ago
AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial
newswire.com
/6 days ago
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
Remission results nearly double published ven/aza outcomes in patients with historically limited treatment success
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Aml
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
newswire.com
Recent coverage from public sources
Public source